The difficulty of treating highly comorbid mood and anxiety disorders
1 has led to increased clinical interest in potential alternative treatments, such as noninvasive brain stimulation techniques, including transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex (DLPFC). A recent meta-analysis
2 of individual data from 289 patients with major depressive disorder treated with tDCS showed that, compared with placebo-controlled clinical trials of antidepressant drugs, sham-controlled clinical trials of DLPFC tDCS had a similar number needed to treat (7 for response, 9 for remission).